Skip to main content
Top
Published in: European Radiology 6/2019

Open Access 01-06-2019 | Diabetes | Cardiac

MR extracellular volume mapping and non-contrast T1ρ mapping allow early detection of myocardial fibrosis in diabetic monkeys

Authors: Yu Zhang, Wen Zeng, Wei Chen, Yushu Chen, Tong Zhu, Jiayu Sun, Zhigang Liang, Wei Cheng, Lei Wang, Bing Wu, Li Gong, Victor A. Ferrari, Jie Zheng, Fabao Gao

Published in: European Radiology | Issue 6/2019

Login to get access

Abstract

Objective

To detect diffuse myocardial fibrosis in different severity levels of left ventricular diastolic dysfunction (DD) in spontaneous type 2 diabetes mellitus (T2DM) rhesus monkeys.

Methods

Eighteen spontaneous T2DM and nine healthy monkeys were studied. Echocardiography was performed for diastolic function classification. Cardiac magnetic resonance (CMR) imaging was performed to obtain extracellular volume fraction (ECV) maps and T1ρ maps at two different spin-locking frequencies. ECV values, T1ρ values, and myocardial fibrosis index (mFI) values which are based on the dispersion of T1ρ, were calculated. Global peak diastolic longitudinal strain rates (GSrL) were also obtained.

Results

Echocardiography results showed mild DD in nine T2DM monkeys and moderate DD in the other nine. The global ECV values were significantly different among healthy animals as compared with animals with mild DD or moderate DD, and the ECV values of animals with moderate DD were significantly higher as compared with those of mild DD. The mFI values increased progressively from healthy animals to those with mild DD and then to those with moderate DD. Diastolic function indicators (e.g., early diastolic mitral annulus velocity, GSrL) correlated well with ECV and mFI.

Conclusions

Monkeys with T2DM exhibit increased ECV, T1ρ, and mFI values, which may be indicative of the expansion of extracellular volume and the deposition of excessive collagen. T1ρ mapping may have the potential to be used for diffuse myocardial fibrosis assessment.

Key Points

Monkeys with T2DM exhibit increased ECV, T1ρ, and mFI values, which may be indicative of the expansion of extracellular volume and the deposition of excessive collagen.
The relationship between diastolic dysfunction and diffuse myocardial fibrosis may be demonstrated by imaging markers.
Non-contrast T1ρ mapping may have the potential to be used for diffuse myocardial assessment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meagher P, Adam M, Civitarese R, Bugyei-Twum A, Connelly KA (2018) Heart failure with preserved ejection fraction in diabetes: mechanisms and management. Can J Cardiol 34:632–643CrossRefPubMed Meagher P, Adam M, Civitarese R, Bugyei-Twum A, Connelly KA (2018) Heart failure with preserved ejection fraction in diabetes: mechanisms and management. Can J Cardiol 34:632–643CrossRefPubMed
2.
go back to reference Mentz RJ, Kelly JP, von Lueder TG et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281–2293CrossRefPubMedPubMedCentral Mentz RJ, Kelly JP, von Lueder TG et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281–2293CrossRefPubMedPubMedCentral
3.
go back to reference Ather S, Chan W, Bozkurt B et al (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998–1005CrossRefPubMedPubMedCentral Ather S, Chan W, Bozkurt B et al (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998–1005CrossRefPubMedPubMedCentral
4.
go back to reference MacDonald MR, Petrie MC, Varyani F et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:1377–1385CrossRefPubMed MacDonald MR, Petrie MC, Varyani F et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:1377–1385CrossRefPubMed
6.
go back to reference Sorop O, Heinonen I, van Kranenburg M et al (2018) Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res 114:954–964CrossRefPubMedPubMedCentral Sorop O, Heinonen I, van Kranenburg M et al (2018) Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening. Cardiovasc Res 114:954–964CrossRefPubMedPubMedCentral
7.
go back to reference Bull S, White SK, Piechnik SK et al (2013) Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 99:932–937CrossRefPubMed Bull S, White SK, Piechnik SK et al (2013) Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 99:932–937CrossRefPubMed
8.
go back to reference Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484CrossRefPubMed Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484CrossRefPubMed
10.
go back to reference Witschey WR, Zsido GA, Koomalsingh K et al (2012) In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:37CrossRefPubMedPubMedCentral Witschey WR, Zsido GA, Koomalsingh K et al (2012) In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:37CrossRefPubMedPubMedCentral
11.
go back to reference Wang C, Zheng J, Sun J et al (2015) Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients. J Cardiol 66:520–526CrossRefPubMed Wang C, Zheng J, Sun J et al (2015) Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients. J Cardiol 66:520–526CrossRefPubMed
12.
go back to reference van Oorschot JW, Güçlü F, de Jong S et al (2017) Endogenous assessment of diffuse myocardial fibrosis in patients with T1rho -mapping. J Magn Reson Imaging 45:132–138CrossRefPubMed van Oorschot JW, Güçlü F, de Jong S et al (2017) Endogenous assessment of diffuse myocardial fibrosis in patients with T1rho -mapping. J Magn Reson Imaging 45:132–138CrossRefPubMed
13.
go back to reference Witschey WR, Pilla JJ, Ferrari G et al (2010) Rotating frame spin lattice relaxation in a swine model of chronic, left ventricular myocardial infarction. Magn Reson Med 64:1453–1460CrossRefPubMedPubMedCentral Witschey WR, Pilla JJ, Ferrari G et al (2010) Rotating frame spin lattice relaxation in a swine model of chronic, left ventricular myocardial infarction. Magn Reson Med 64:1453–1460CrossRefPubMedPubMedCentral
15.
go back to reference Schleichert RA, Seliger SL, Zhan M, Gaspari AA (2012) Nephrogenic systemic fibrosis and diabetes mellitus. Arch Dermatol 148:255–257CrossRefPubMed Schleichert RA, Seliger SL, Zhan M, Gaspari AA (2012) Nephrogenic systemic fibrosis and diabetes mellitus. Arch Dermatol 148:255–257CrossRefPubMed
16.
go back to reference Gong L, Zeng W, Yang Z et al (2013) Comparison of the clinical manifestations of type 2 diabetes mellitus between rhesus monkey (Macaca mulatta lasiotis) and human being. Pancreas 42:537–542CrossRefPubMed Gong L, Zeng W, Yang Z et al (2013) Comparison of the clinical manifestations of type 2 diabetes mellitus between rhesus monkey (Macaca mulatta lasiotis) and human being. Pancreas 42:537–542CrossRefPubMed
17.
go back to reference Xu Z, Zeng W, Sun J et al (2017) The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus. Neuroimage 158:480–487CrossRefPubMed Xu Z, Zeng W, Sun J et al (2017) The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus. Neuroimage 158:480–487CrossRefPubMed
18.
go back to reference Hansen BC (2012) Investigation and treatment of type 2 diabetes in nonhuman primates. Methods Mol Biol 933:177–185PubMed Hansen BC (2012) Investigation and treatment of type 2 diabetes in nonhuman primates. Methods Mol Biol 933:177–185PubMed
19.
go back to reference Kasner M, Westermann D, Steendijk P et al (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116:637–647CrossRefPubMed Kasner M, Westermann D, Steendijk P et al (2007) Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 116:637–647CrossRefPubMed
20.
go back to reference Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
21.
go back to reference Qian C, Gong L, Yang Z et al (2015) Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging. BMC Cardiovasc Disord 15:59CrossRefPubMedPubMedCentral Qian C, Gong L, Yang Z et al (2015) Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging. BMC Cardiovasc Disord 15:59CrossRefPubMedPubMedCentral
22.
go back to reference Kellman P, Wilson JR, Xue H, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 14:63CrossRefPubMedPubMedCentral Kellman P, Wilson JR, Xue H, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 14:63CrossRefPubMedPubMedCentral
23.
go back to reference Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed
24.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed
25.
go back to reference Hansen BC, Newcomb JD, Chen R, Linden EH (2013) Longitudinal dynamics of body weight change in the development of type 2 diabetes. Obesity (Silver Spring) 21:1643–1649CrossRef Hansen BC, Newcomb JD, Chen R, Linden EH (2013) Longitudinal dynamics of body weight change in the development of type 2 diabetes. Obesity (Silver Spring) 21:1643–1649CrossRef
26.
go back to reference Gu H, Liu Y, Mei S et al (2015) Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes. BMC Cardiovasc Disord 15:141CrossRefPubMedPubMedCentral Gu H, Liu Y, Mei S et al (2015) Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes. BMC Cardiovasc Disord 15:141CrossRefPubMedPubMedCentral
27.
go back to reference Ernande L, Thibault H, Bergerot C et al (2012) Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: identification at MR imaging with cine displacement encoding with stimulated echoes. Radiology 265:402–409CrossRefPubMedPubMedCentral Ernande L, Thibault H, Bergerot C et al (2012) Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: identification at MR imaging with cine displacement encoding with stimulated echoes. Radiology 265:402–409CrossRefPubMedPubMedCentral
28.
go back to reference Wilmot EG, Leggate M, Khan JN et al (2014) Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction. Diabet Med 31:794–798CrossRefPubMed Wilmot EG, Leggate M, Khan JN et al (2014) Type 2 diabetes mellitus and obesity in young adults: the extreme phenotype with early cardiovascular dysfunction. Diabet Med 31:794–798CrossRefPubMed
29.
go back to reference Khan JN, Wilmot EG, Leggate M et al (2014) Subclinical diastolic dysfunction in young adults with type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. Eur Heart J Cardiovasc Imaging 15:1263–1269CrossRefPubMed Khan JN, Wilmot EG, Leggate M et al (2014) Subclinical diastolic dysfunction in young adults with type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. Eur Heart J Cardiovasc Imaging 15:1263–1269CrossRefPubMed
30.
go back to reference Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533–1542CrossRefPubMed Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533–1542CrossRefPubMed
31.
go back to reference Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12:144–153CrossRefPubMed Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12:144–153CrossRefPubMed
32.
go back to reference Su MY, Lin LY, Tseng YH et al (2014) CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging 7:991–997CrossRefPubMed Su MY, Lin LY, Tseng YH et al (2014) CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging 7:991–997CrossRefPubMed
33.
go back to reference Wong TC, Piehler KM, Kang IA et al (2014) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35:657–664CrossRefPubMed Wong TC, Piehler KM, Kang IA et al (2014) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35:657–664CrossRefPubMed
34.
go back to reference Cao Y, Zeng W, Cui Y et al (2018) Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain. Cardiovasc Diabetol 17:7CrossRefPubMedPubMedCentral Cao Y, Zeng W, Cui Y et al (2018) Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain. Cardiovasc Diabetol 17:7CrossRefPubMedPubMedCentral
35.
go back to reference Musthafa HS, Dragneva G, Lottonen L et al (2013) Longitudinal rotating frame relaxation time measurements in infarcted mouse myocardium in vivo. Magn Reson Med 69:1389–1395CrossRefPubMed Musthafa HS, Dragneva G, Lottonen L et al (2013) Longitudinal rotating frame relaxation time measurements in infarcted mouse myocardium in vivo. Magn Reson Med 69:1389–1395CrossRefPubMed
36.
go back to reference Cobb JG, Xie J, Gore JC (2013) Contributions of chemical and diffusive exchange to T1rho dispersion. Magn Reson Med 69:1357–1366CrossRefPubMed Cobb JG, Xie J, Gore JC (2013) Contributions of chemical and diffusive exchange to T1rho dispersion. Magn Reson Med 69:1357–1366CrossRefPubMed
37.
39.
go back to reference Zeng M, Zhang N, He Y et al (2016) Histological validation of cardiac magnetic resonance T1 mapping for detecting diffuse myocardial fibrosis in diabetic rabbits. J Magn Reson Imaging 44:1179–1185CrossRefPubMed Zeng M, Zhang N, He Y et al (2016) Histological validation of cardiac magnetic resonance T1 mapping for detecting diffuse myocardial fibrosis in diabetic rabbits. J Magn Reson Imaging 44:1179–1185CrossRefPubMed
40.
go back to reference Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging 6:672–683CrossRefPubMedPubMedCentral Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging 6:672–683CrossRefPubMedPubMedCentral
41.
go back to reference Joubert M, Bellevre D, Legallois D et al (2016) Hyperglycemia-induced hypovolemia is involved in early cardiac magnetic resonance alterations in streptozotocin-induced diabetic mice: a comparison with furosemide-induced hypovolemia. PLoS One 11:e0149808CrossRefPubMedPubMedCentral Joubert M, Bellevre D, Legallois D et al (2016) Hyperglycemia-induced hypovolemia is involved in early cardiac magnetic resonance alterations in streptozotocin-induced diabetic mice: a comparison with furosemide-induced hypovolemia. PLoS One 11:e0149808CrossRefPubMedPubMedCentral
Metadata
Title
MR extracellular volume mapping and non-contrast T1ρ mapping allow early detection of myocardial fibrosis in diabetic monkeys
Authors
Yu Zhang
Wen Zeng
Wei Chen
Yushu Chen
Tong Zhu
Jiayu Sun
Zhigang Liang
Wei Cheng
Lei Wang
Bing Wu
Li Gong
Victor A. Ferrari
Jie Zheng
Fabao Gao
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5950-9

Other articles of this Issue 6/2019

European Radiology 6/2019 Go to the issue